Portage Biotech Inc., a clinical-stage immuno-oncology company focused on overcoming cancer treatment resistance, entered into an agreement with Merck.
Pavan Reddy’s motivations to apply for the director’s job at Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center included his own research interests.
Robert Uzzo was named president and CEO of Fox Chase Cancer Center, following a period of interim leadership.
Jarett Rieger was named vice president and chief innovation officer at Moffitt Cancer Center.
Antonio Iavarone was named deputy director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.
Jeannie Shen was appointed medical director of the Breast Program at Huntington Hospital, an affiliate of Cedars-Sinai, and medical director of the International Health Program at Cedars-Sinai Cancer at Huntington Hospital.
Roy S. Herbst received an award of appreciation by the SWOG Cancer Research Network for his passion, commitment, leadership, and enduring dedicated service to the ground-breaking Lung-MAP protocol. The award was given at a commemorative dinner during the SWOG Annual Meeting.
Brad Diephuis was named chief business officer of Thyme Care, an oncology care management solution providing tech-enabled cancer care navigation (The Cancer Letter, Oct. 7, 2022).
The Houston Astros beat the New York Yankees in the American League Championship Series, settling a Twitter bet between MD Anderson and Memorial Sloan Kettering’s presidents Peter W.T. Pisters and Selwyn M. Vickers.
A new study led by a University of Cincinnati researcher provides more clarity on how immunotherapy treatment for patients with cancer affects COVID-19 severity.
